After the vasculitis clinic was established, hospitalizations for any cause dropped significantly from 70 to 51 admissions per 100 person-years.

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

Measles may reestablish endemicity, with an estimated 851,300 cases over 25 years at current vaccination rates.

Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists.

Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas.

The ProVIDE study is a prospective, randomized, double-blind, sham controlled study evaluating the safety and effectiveness of the ProVee® Urethral Expander System for the treatment of lower urinary ...

(HealthDay News) — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study published online March 17 in ...

Barriers contributing to underreporting of fatigue also include belief that symptom is sign disease is progressing and attempt to be a “good patient.” A cross-sectional study compared barriers to ...

Cancer drugs conferring low or no therapeutic benefits accounted for $6.7 billion in post-rebate Medicare spending in 2022.

There have been no prospective studies comparing stent use vs nonuse after ureteroscopy for uncomplicated renal stones.

At univariable analysis, both anti-C1q antibodies and non-use of hydroxychloroquine predicted renal flares at baseline and 6 and 12 months. Proteinuria (24/h proteinuria and proteinuria 0.5 g/day or ...

BOND-003 evaluated the efficacy and safety of cretostimogene grenadenorepvec, an oncolytic immunotherapy, in patients with carcinoma in situ BCG-unresponsive NMIBC.